These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1966973)

  • 21. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
    Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.
    Adiseshaiah P; Dellinger A; MacFarland D; Stern S; Dobrovolskaia M; Ileva L; Patri AK; Bernardo M; Brooks DB; Zhou Z; McNeil S; Kepley C
    Invest Radiol; 2013 Nov; 48(11):745-54. PubMed ID: 23748228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mn-TPPS4; a potential MRI contrast agent for localizing the normal aortic wall in rabbits].
    Kim SW; Kozuka T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Feb; 50(2):192-4. PubMed ID: 2362799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biocompatible KMnF3 nanoparticular contrast agent with proper plasma retention time for in vivo magnetic resonance imaging.
    Liu ZJ; Song XX; Xu XZ; Tang Q
    Nanotechnology; 2014 Apr; 25(15):155101. PubMed ID: 24642699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multimodal magnetic resonance imaging nanoplatform for cancer theranostics.
    Benyettou F; Lalatonne Y; Chebbi I; Di Benedetto M; Serfaty JM; Lecouvey M; Motte L
    Phys Chem Chem Phys; 2011 Jun; 13(21):10020-7. PubMed ID: 21409252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual probe with fluorescent and magnetic properties for imaging solid tumor xenografts.
    Shan L; Wang S; Sridhar R; Bhujwalla ZM; Wang PC
    Mol Imaging; 2007; 6(2):85-95. PubMed ID: 17445503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An intravascular MRI contrast agent based on Gd(DO3A-Lys) for tumor angiography.
    Yang CT; Chandrasekharan P; He T; Poh Z; Raju A; Chuang KH; Robins EG
    Biomaterials; 2014 Jan; 35(1):327-36. PubMed ID: 24138829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modifications in dynamic contrast-enhanced magnetic resonance imaging parameters after α-particle-emitting ²²⁷Th-trastuzumab therapy of HER2-expressing ovarian cancer xenografts.
    Heyerdahl H; Røe K; Brevik EM; Dahle J
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):153-9. PubMed ID: 23790511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 9.4 T imaging studies of human tumor xenografts in nude mice.
    Sarkar SK; Mattingly MA; Kline T; Greig R
    Invest Radiol; 1988 Sep; 23(9):677-9. PubMed ID: 3182215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of early docetaxel response in an experimental model of human breast cancer using DCE-MRI, ex vivo HR MAS, and in vivo 1H MRS.
    Jensen LR; Huuse EM; Bathen TF; Goa PE; Bofin AM; Pedersen TB; Lundgren S; Gribbestad IS
    NMR Biomed; 2010 Jan; 23(1):56-65. PubMed ID: 19650073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydrothermally synthesized PEGylated calcium phosphate nanoparticles incorporating Gd-DTPA for contrast enhanced MRI diagnosis of solid tumors.
    Mi P; Kokuryo D; Cabral H; Kumagai M; Nomoto T; Aoki I; Terada Y; Kishimura A; Nishiyama N; Kataoka K
    J Control Release; 2014 Jan; 174():63-71. PubMed ID: 24211705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor microvascular changes in antiangiogenic treatment: assessment by magnetic resonance contrast media of different molecular weights.
    Turetschek K; Preda A; Novikov V; Brasch RC; Weinmann HJ; Wunderbaldinger P; Roberts TP
    J Magn Reson Imaging; 2004 Jul; 20(1):138-44. PubMed ID: 15221819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hepatic metastasis of human colon carcinoma: establishment of a nude mouse model and its magnetic resonance imaging].
    Xie Q; Liang BL; Jiang XQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):97-100. PubMed ID: 18227037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chlorotoxin-modified macromolecular contrast agent for MRI tumor diagnosis.
    Huang R; Han L; Li J; Liu S; Shao K; Kuang Y; Hu X; Wang X; Lei H; Jiang C
    Biomaterials; 2011 Aug; 32(22):5177-86. PubMed ID: 21531455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanotemplate-engineered nanoparticles containing gadolinium for magnetic resonance imaging of tumors.
    Zhu D; Lu X; Hardy PA; Leggas M; Jay M
    Invest Radiol; 2008 Feb; 43(2):129-40. PubMed ID: 18197065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammation targeted Gd(3+)-based MRI contrast agents imaging tumor and rheumatoid arthritis models.
    Leung AH; Jin J; Wang S; Lei H; Wong WT
    Bioconjug Chem; 2014 Jun; 25(6):1112-23. PubMed ID: 24857314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isointense model for the evaluation of tumor-specific MRI contrast agents.
    Button TM; Fiel RJ
    Magn Reson Imaging; 1988; 6(3):275-80. PubMed ID: 3398734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative study of manganese meso-sulfonatophenyl porphyrins: contrast-enhancing agents for tumors.
    Fiel RJ; Musser DA; Mark EH; Mazurchuk R; Alletto JJ
    Magn Reson Imaging; 1990; 8(3):255-9. PubMed ID: 2366638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the mechanism of selective retention of porphyrins and metalloporphyrins by cancer cells.
    Megnin F; Faustino PJ; Lyon RC; Lelkes PI; Cohen JS
    Biochim Biophys Acta; 1987 Jul; 929(2):173-81. PubMed ID: 3593779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proton relaxation enhancement by manganese(III)TPPS4 in a model tumor system.
    Fiel RJ; Button TM; Gilani S; Mark EH; Musser DA; Henkelman RM; Bronskill MJ; van Heteren JG
    Magn Reson Imaging; 1987; 5(2):149-56. PubMed ID: 3586881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.